More recently, re-activation of RB in a lung adenocarcinoma model driven by oncogenic K-RAS and loss of both RB and p53 was achieved using a new mouse allele in which endogenous RB expression can be genetically turned off and then back on [26]. Here, RB1 is linked to lung adenocarcinoma.